文献速递乳腺MR乳腺X线US

乳腺癌平均风险女性的补充乳腺MR成像筛查

Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
PubMed 文献 · Radiology · 2017-02-21

这项前瞻性观察研究在两家学术乳腺中心纳入2120名40-70岁无乳腺癌相关危险因素(终生风险<15%)的女性,共进行3861次补充MR筛查,覆盖7007女性年。MR补充检出60例额外乳腺癌(总体补充检出率15.5/1000例,95%CI 11.9-20.0),未观察到间期癌,特异度97.1%、阳性预测值35.7%。作者结论认为在平均风险女性中,MR筛查改善了对预后相关乳腺癌的早期诊断。

要点

  • 平均风险女性补充MR筛查总体额外检出率15.5/1000例(95%CI 11.9-20.0)。
  • MR检出癌中位大小8mm,93.4%淋巴结阴性,无间期癌。
  • MR筛查特异度97.1%、阳性预测值35.7%。

核心结论

  • 在乳腺癌平均风险女性中,MR成像筛查改善了对预后相关乳腺癌的早期诊断。

研究设计与样本

  • 前瞻性观察研究,在两家学术乳腺中心纳入2120名40-70岁无乳腺癌相关危险因素(终生风险<15%)的女性,2005年1月至2013年12月间对常规影像(筛查乳腺X线摄影伴或不伴筛查超声)正常者行补充MR筛查,共3861次MR筛查、覆盖7007女性年,以组织学诊断或2年随访为参考标准。

诊断标准与关键数值

  • 补充癌症检出率总体为15.5/1000例(95%CI 11.9,20.0);初次筛查48例,补充检出率22.6/1000例;后续1741轮筛查中13例新发癌有12例仅由MR检出,补充检出率6.9/1000例。MR筛查特异度97.1%(95%CI 96.5,97.6),阳性预测值35.7%(95%CI 28.9,43.1)。

临床应用与阅片要点

  • 作者结论认为,在乳腺癌平均风险女性中,MR成像筛查改善了对预后相关乳腺癌的早期诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the utility and accuracy of breast magnetic resonance (MR) imaging as a supplemental screening tool in women at average risk for breast cancer and to investigate the types of cancer detected with MR imaging screening. Materials and Methods This prospective observational study was conducted at two academic breast centers in women aged 40-70 years without breast cancer-associated risk factors (lifetime risk <15%). Between January 2005 and December 2013, women with at least minimal residual breast tissue (American College of Radiology categories A-D) and normal conventional imaging findings (screening mammography with or without screening ultrasonography [US]) were invited to undergo supplemental MR imaging screening. Outcome measures were supplemental cancer detection rates, interval cancer rates, and biologic profiles of MR imaging-detected additional cancers, as well as specificity and positive predictive value (PPV) of MR imaging screening. Tissue diagnoses or 2 years of follow-up were used to establish the reference standard. Results A total of 2120 women were recruited and underwent 3861 screening MR imaging studies, covering an observation period of 7007 women-years. Breast MR imaging depicted 60 additional breast cancers (ductal carcinoma in situ, n = 20; invasive carcinoma, n = 40) for an overall supplemental cancer detection rate of 15.5 per 1000 cases (95% confidence interval [CI]: 11.9, 20.0). Forty-eight additional cancers were detected with MR imaging at initial screening (supplemental cancer detection rate, 22.6 per 1000 cases). During the 1741 subsequent screening rounds, 12 of 13 incident cancers were found with MR imaging alone (supplemental cancer detection rate, 6.9 per 1000 cases). One cancer was diagnosed with all three methods (mammography, US, and MR imaging), and none were diagnosed with mammography only or US only. Cancers diagnosed with MR imaging were small (median, 8 mm), node negative in 93.4% of cases, and dedifferentiated (high-grade cancer) in 41.7% of cases at prevalence screening and 46.0% of cases at incidence screening. No interval cancers were observed. MR imaging screening offered high specificity (97.1%; 95% CI: 96.5, 97.6) and high PPV (35.7%; 95% CI: 28.9, 43.1). Conclusion In women at average risk for breast cancer, MR imaging screening improves early diagnosis of prognostically relevant breast cancer. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kuhl CK, Strobel K, Bieling H, et al. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer. Radiology. 2017. PMID: 28221097. doi:10.1148/radiol.2016161444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。